Keywords: A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Abacavir; NRTIs; Platelet-endothelium interactions; Cardiovascular diseases;
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2â²-deoxy-2â²-fluoro- 4â²-azido nucleoside derivatives as potent anti-HBV agents
Keywords: 2â²-deoxy-2â²-β-fluoro-4â²-azido-β-d-arabinofuranosyl 1,2,3-triazole nucleoside; Anti-HBV activity; Nucleoside reverse transcriptase inhibitor (NRTI); Lamivudine-resistant HBV mutants; Viral DNA replication; HBV; hepatitis B virus; HCV; hepatitis C v
Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation
Keywords: EFV; efavirenz; NNRTI; non-nucleoside reverse transcriptase inhibitor; HIV-1/AIDS; human immunodeficiency virus type 1 infection; SLS; sodium lauryl sulfate; HPC; hydroxypropylcellulose; HPMC; hydroxypropylmetilcellulose; NRTIs; nucleoside reverse transcr
Untangling the Gordian knot of HIV, stress, and cognitive impairment
Keywords: HIV; Stress; Inflammation; CD4; Cognition; IL-1β; Interleukin-1β; IL-2; Interleukin-2; IL-6; Interleukin-6; IL-12; Interleukin-12; IL-18; Interleukin-18; ACTH; Adrenocorticotropic hormone; AIDS; Acquired immune deficiency syndrome; ANI; Asymptomatic neu
Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo
Keywords: HIV; Human immunodeficiency virus; HAART; Highly active anti-retroviral therapy; AIDS; Acquired immunodeficiency virus syndrome; 3Tc; Lamivudine; FTC; Emtricitabine; BCS; Biopharmaceutical Classification System; CNS; Central nervous system; BBB; Blood Bra
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy
Keywords: aODN; antisense oligonucleotide; CaMKII; Ca2Â +-calmodulin-dependent kinase II; ddC; 2â²,3â²-dideoxycitidine; dODN; degenerate oligonucleotide; ELAV protein; embryonic lethal abnormal vision protein; HIV-SN; HIV-associated sensory neuropathy; i.p.; intr
Leptin in congenital and HIV-associated lipodystrophy
Keywords: POMC; pro-opiomelanocortin; NPY; neuropeptide Y; MRI; magnetic resonance imaging; AMPK; adenosine monophosphate-activated protein kinase; HIV; Human Immunodeficiency Virus; HALS; HIV-associated lipodystrophy syndrome; CT; computed tomography; DEXA; dual-e
Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold
Keywords: CCR5; CC chemokine receptor type 5; CXCR4; CXC chemokine receptor type 4; MAGI; multinuclear activation of a galactosidase indicator; NNRTIs; non-nucleoside reverse transcriptase inhibitors; NRTIs; nucleoside reverse transcriptase inhibitors; PIs; proteas
Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance
Keywords: HAART; Highly Active Antiretroviral Therapy; NRTIs; Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNRTIs; Non-Nucleoside Reverse Transcriptase Inhibitors; Genotype; Drug resistance; HIV-1;
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy
Keywords: HIV infection; cART; Maraviroc; NRTIs; Inflammatory markers;
Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors
Keywords: APC; Allophycocyanin fluorochrome; DMSO; Dimethylsulfoxide; FITC; Fluorescein isothiocyanate fluorochrome; HAART; Highly Active Antiretroviral Therapy; II; Integrase inhibitor; MFI; Median fluorescence intensity; MDR; Multi-drug resistance; NNRTI; Non-nuc
Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review
Keywords: ABC; ATP-binding cassette superfamily; ART; Antiretroviral therapy; AUC; Area-Under-the-Curve; BCS; Biopharmaceutic Classification System; BCRP; Breast cancer resistance protein; CD; Cyclodextrins; CFR; Code of Federal Regulations; CMC; Critical Micellar
Bifunctional inhibition of HIV-1 reverse transcriptase: A first step in designing a bifunctional triphosphate
Keywords: HIV-1; human immunodeficiency virus type 1; RT; reverse transcriptase; NRTIs; nucleoside RT inhibitors; NNRTIs; nonnucleoside RT inhibitors; dNTP; deoxynucleoside triphosphate; dNMP; 3â²-deoxynucleoside monophosphate; PPi; pyrophosphate; AZT; β-d-(+)-3â
Antiviral therapies: Focus on hepatitis B reverse transcriptase
Keywords: HBV; Hepatitis B virus; HBsAg; HBV surface antigen; HBeAg; HBV e antigen; RT; reverse transcriptase; NRTI; nucleoside reverse transcriptase inhibitor; LVD/3TC; lamivudine; ADV; adefovir dipivoxil; ETV; entecavir; LdT; telbivudine; TDF; tenofovir disoproxi
In search of a selective therapy of viral infections
Keywords: Double-stranded RNA; β-Interferon; Reverse transcriptase; NRTIs; NtRTIs; NNRTIs; Acyclovir; BVDU
Synthesis, structure–activity relationship and antiviral activity of 3′-N,N-dimethylamino-2′,3′-dideoxythymidine and its prodrugs
Keywords: Dideoxythymidine; NRTIs; VSV; HIV-1; HIV-1 RT; MTT assay
Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Keywords: HIV drug resistance; Microbicides; NNRTIs; NRTIs
Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073)
Keywords: PI; protease inhibitor; AZT; zidovudine; d4T; stavudine; 3TC; lamivudine; ddI; didanosine; ddC; zalcitabine; IDV; indinavir; NFV; nelfinavir; APV; amprenavir; RT; reverse transcriptase; PR; protease; HIV; human immunodeficiency virus; M8; nelfinavir hydro
Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy
Keywords: FDA; Food and Drug Administration; HAART; highly active antiretroviral therapy; NNRTIs; non-nucleoside reverse transcriptase inhibitors; NRTIs; nucleoside reverse transcriptase inhibitors; OSHA; Occupational Health and Safety Administration; PUI; personal
HIV chemokine receptor inhibitors as novel anti-HIV drugs
Keywords: AIDS; acquired immune deficiency syndrome; AOP; aminooxypentane; CI; clinical isolate; DC; dendritic cell; DC-SIGN; dendritic cell-specific ICAM-3-grabbing nonintegrin; FDA; Food and Drug Administration; FLIPR; fluorometric imaging plate reader; GCP; gran